Gate Neurosciences

News

Gate Neurosciences' antidepressant apimostinel has started a proof-of-concept study to see if its efficacy can be boosted by a digital training tool.

News

Kyverna has data with miv-cel in stiff person syndrome that shows durable efficacy and safety and seems to sidestep issues flagged with other CAR-Ts.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.